Search

everythinglearnresearchcommunity

for

Search:↓

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

JAK inhibitors might help treat Lichen Planopilaris, but more research is needed.

Gefitinib can cause hair and eyebrow darkening.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

ZD1839 can cause skin issues like acne and hair changes.

Gefitinib can cause rare scarring hair loss.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Dermal EZH2 controls skin cell development and hair growth in mice.

Scalp involvement in pemphigus means the disease is more severe and harder to treat.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Individualized treatments may help manage Dercum's disease symptoms.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

The pony's skin condition improved significantly with prednisolone treatment.